Anabolic Hormone replacement, a new era!



Hormone replacement market (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism.



Summary

·         The global healthcare information software market reached a value of 
 approximately US$ 3.9 Billion in 2017.
·        The market value is projected to reach around US$ 5.9 Billion by 2023,
registering a CAGR of 7.2% during 2018-2023.
·        Hormone replacement therapy (HRT) is used for replenishing the hormones
that are present in low levels in the human body.
·        Treatment is particularly favourable for patients with growth hormone 
deficiency, women nearing menopause and elderly people suffering from
hypogonadism.


Major Regions

Based on product type, estrogen replacement therapy accounts for the majority of the global share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

Key Players

·        Abbott Laboratories
·        Bayer AG
·        Eli Lilly & Company
·        Roche
·        Hisamitsu Pharmaceutical Co. Inc.
·        Merck
·        Mylan
·        Novartis
·        Novo Nordisk and Pfizer.

For more inquiry contact our sales team at contact@aarkstore.com

Category of Report:


Related Reports:




Contact Details:

Aarkstore Enterprise
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242

Email: contact@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog/




Comments

Popular posts from this blog

India travels across!

A detailed SWOT report on A.P. Moller – Maersk

Examining Closed-circuit TVs